Donanemab in Early Symptomatic Alzheimer Disease
2023 · JAMA · 2,176 citations
https://doi.org/10.1001/jama.2023.13239
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
15
Citations
3
h-index
0
i10-index
Marcin Ratajczak is an academic researcher. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Alzheimer's disease research and treatments & Corporate Social Responsibility Reporting. The author has an h-index of 3, co-authored 7 publications.
ORCID: 0000-0003-1072-8380Click to start Chat